Approval · Notice of Compliance 26470 · 2021
TRANEXAMIC ACID: Notice of Compliance 26470
Issued August 18, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26470
- Date
- August 18, 2021
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Companies
- Canadian reference product
- CYKLOKAPRON (Meda Pharmaceuticals Ltd)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRANEXAMIC ACID | 02519194 | Marketed |
Medicinal ingredients
- TRANEXAMIC ACID 500 MG per TAB